A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
Norishige Yoshikawa(Takatsuki General Hospital), Kazumoto Iijima(Kobe Children's Hospital), Koichi Nakanishi(University of the Ryukyus), Rintaro Mori(National Center For Child Health and Development), Erika Ota(St. Luke's International University), Hiroshi Kaito(Kobe University), Yuko Shima(Wakayama Medical University), Shuichi Ito(Yokohama City University), Hiroshi Hataya(Japanese Society for Dialysis Therapy), Kenji Ishikura(Kitasato University), Mari S. Oba(Yokohama City University), Yasuo Ohashi(Chuo University), Takashi Igarashi(National Center For Child Health and Development), Masataka Honda(Rikkyo University), Kandai Nozu(Kobe Children's Hospital), Mayumi Sako(National Center For Child Health and Development), Hidefumi Nakamura(National Center For Child Health and Development)
Cited by 135
Related Papers
Use of the Robson classification to assess caesarean section trends in 21 countries: a secondary analysis of two WHO multicountry surveys
|The Lancet Global Health|2015|1k
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
|Journal of Clinical Oncology|2013|632
Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels
|Pediatric Research|2013|498
A global reference for fetal-weight and birthweight percentiles
|The Lancet|2011|476